SCHEMBL15717320

SCHEMBL15717320

CCCCCOC(=O)Nc1ccn(C2OC(CO)C(O)C2(F)F)c(=O)n1

nearest known ligand 0.75

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
PDE4D Q08499 1/20 0.55
PDE3A Q14432 1/20 0.55
SLC29A1 Q99808 1/20 0.55
LMNA P02545 1/20 0.47
POLA1 P09884 2/20 0.44
POLB P06746 1/20 0.38
P2RY2 P41231 1/20 0.36
CDA P32320 2/20 0.36
PRMT5 O14744 1/20 0.36
WDR77 Q9BQA1 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13160995 1.00 PDE4D (0.55) PDE4DPDE3ASLC29A1LMNAPOLA1
SCHEMBL15675815 0.99 PDE4D (0.54) PDE4DPDE3ASLC29A1LMNAPOLA1
SCHEMBL15675784 0.99 PDE4D (0.54) PDE4DPDE3ASLC29A1LMNAPOLA1
SCHEMBL15675962 0.97 PDE4D (0.56) PDE4DPDE3ASLC29A1LMNAPOLA1
SCHEMBL19698969 0.97 PDE4D (0.56) PDE4DPDE3ASLC29A1LMNAPOLA1
SCHEMBL23700177 0.95 PDE4D (0.50) PDE4DPDE3ASLC29A1LMNAPOLA1
SCHEMBL18759734 0.92 PDE4D (0.46) PDE4DPDE3ASLC29A1LMNAPOLA1
SCHEMBL13160999 0.91 POLA1 (0.48) PDE4DPDE3ASLC29A1LMNAPOLA1
SCHEMBL13161034 0.91 POLA1 (0.48) PDE4DPDE3ASLC29A1LMNAPOLA1
SCHEMBL13160971 0.90 PDE4D (0.60) PDE4DPDE3ASLC29A1LMNAPOLA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2919790-A1 GEMCITABINE PRODRUGS AND USES THEREOF Boyen Therapeutics, Inc. (TW) 2015-09-23 EP disclosed
WO-2014078295-A1 GEMCITABINE PRODRUGS AND USES THEREOF BoYen Therapeutics, Inc. (TW) 2014-05-22 WO disclosed